Recombinant Anti-CD4 × Anti-IL2 Bispecific Antibody (CrossMab) (CAT#: CROSS-L014)
Recombinant Anti-CD4 × Anti-IL2 Bispecific Antibody (CrossMab) has been generated by applying the Crossmab format to generate an IgG shaped entity that binds each ligand with one arm. This BsAb is capable of inhibiting signaling of their cognate receptors and a combined blockade of them has a greater inhibitory efficacy compared with inhibition of either factor alone. It was designed for the treatment of ADIS.
Specific Inquiry
Specifications
- Target
- CD4 & IL2
- Type
- CrossMab
- Species Reactivity
- Human
- Target 1
- CD4
- Host Species 1
- Mouse
- Target 2
- IL2
- Host Species 2
- Mouse
- Application
- FuncS, Promising therapeutic agent
- Related Disease
- ADIS
Target
- Target 1
- CD4
- Gene ID
- 920
- UniProt ID
- B4DT49
- Alternative Names
- CD4; CD4 molecule; CD4mut; T-cell surface glycoprotein CD4; CD4 receptor; CD4 antigen (p55); T-cell surface antigen T4/Leu-3
- Target 2
- IL2
- Gene ID
- 3558
- UniProt ID
- P60568
- Alternative Names
- IL2; interleukin 2; IL-2; TCGF; lymphokine; interleukin-2; aldesleukin; T cell growth factor; involved in regulation of T-cell clonal expansion
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for CROSS-L014. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.